CHD Scientists Uncover Evidence of Pfizer ‘Hot Lots’ Linked to Higher Rates of COVID Vaccine Injuries
Link: https://childrenshealthdefense.org/defender/pfizer-hot-lots-covid-vaccine-injuries-chd-research/
Different batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the U.S. had very different rates of serious adverse events, according to a peer-reviewed research letter by the Children’s Health Defense science team. The letter was published late yesterday in Science, Public Health Policy and the Law. Different batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the U.S. had very different rates of serious adverse events (SAEs), according to a peer-reviewed research letter published late Thursday in Science, Public Health Policy and the Law. Children’s Health Defense (CHD) scientists Brian Hooker, Ph.D, chief scientific officer, and Karl Jablonowski, Ph.D., senior research scientist, co-authored the letter. Hooker and Jablonowski found the highest SAE rates occurred in COVID-19 vaccine batches distributed during the first two months of the vaccination program — and the highest proportions of those batches were sent to government agencies, hospitals, universities and health departments, as opposed to clinics, pharmacies and doctor’s offices. The “extremely high” amount of variability from lot to lot suggests “very poor manufacturing controls,” and a “manufacturing process that should have never been approved in the first place,” Hooker told The Defender.
No feedback yet
